Explore how sponsor and industry leaders believe clinical operations talent must evolve to support the future of trial delivery
The Clinical Research Associate has long been central to trial execution. But the expectations of the role are changing.
Featuring perspectives from industry leaders at AstraZeneca, Boehringer Ingelheim Pharmaceuticals Inc., IPSEN, and a veteran biopharmaceutical executive with leadership experience across Merck, Sanofi, and Johnson & Johnson, this whitepaper explores what this shift means for clinical operations and workforce strategy.
Why this matters:
Clinical trials are becoming more complex, decentralized, and data-driven. At the same time:
- Hiring difficulty continues to increase
- Site expectations are changing
- Traditional workforce models are under pressure
- Organizations that fail to adapt their talent strategies risk creating future delivery constraints
- This paper explores what comes next
Don’t want to receive these emails? No problem, simply click on the Unsubscribe link below.
By accessing this content, you are permitting Pharma Ignite or a third party to contact you regarding the content (by phone or email).
© 2026 marketingmastershub.com. All rights reserved.